文献速递流行病学与生物统计基础与转化研究

维生素D与2型糖尿病风险的孟德尔随机化研究

Association of vitamin D with risk of type 2 diabetes: A Mendelian randomisation study in European and Chinese adults.
PubMed 文献 · PLoS Med · 2018-05-02

该研究利用中国嘉道理生物样本库及10项研究的荟萃分析,采用孟德尔随机化方法评估血浆25(OH)D浓度与2型糖尿病风险的因果关联。基于两个合成SNP的遗传评分显示,25(OH)D每升高25 nmol/l,糖尿病风险降低14%(95%CI 3%-23%,p=0.01),与生化测量结果方向一致,提示较高25(OH)D对预防糖尿病可能具有因果效应。

要点

  • 遗传评分(2个合成SNP)提示25(OH)D每升高25 nmol/l,糖尿病风险降低14%。
  • 生化测量25(OH)D每升高25 nmol/l,糖尿病风险降低9%(95%CI 0%-18%)。
  • 含4个SNP的遗传评分与糖尿病风险关联不显著(风险降低8%,95%CI -1%至16%,p=0.07),且存在多效性证据。

核心结论

  • 生化测量与遗传工具(合成SNP)估计的25(OH)D差异对糖尿病风险呈现一致关联,支持较高25(OH)D预防糖尿病的因果效应。

研究设计与样本

  • 在中国嘉道理生物样本库(CKB)中,利用4个25(OH)D相关SNP(n=82,464)、血浆25(OH)D(n=13,565)和糖尿病病例(n=5,565)进行孟德尔随机化分析。
  • CKB结果与10项研究(2个合成SNP,n=58,312例病例)和7项研究(全部4个SNP,n=32,796例病例)的荟萃分析合并。

主要发现

  • CKB中平均(SD)25(OH)D浓度为62(20)nmol/l。
  • 遗传评分每等位基因对25(OH)D的效应:合成SNP为2.87(SE 0.39),全部4个SNP为3.54(SE 0.32)。
  • CKB中生化测量25(OH)D每升高25 nmol/l,糖尿病风险降低9%(95%CI 0%-18%)。
  • 全部研究荟萃分析中,基于2个合成SNP的遗传工具25(OH)D每升高25 nmol/l,糖尿病风险降低14%(95%CI 3%-23%,p=0.01)。
  • 基于4个SNP的遗传评分对应25(OH)D差异与糖尿病风险关联不显著(比值比降低8%,95%CI -1%至16%,p=0.07),且有多效性证据。

临床怎么用

  • 该研究提示维持较高25(OH)D水平可能有助于预防2型糖尿病,但需结合个体情况评估,不能仅凭遗传证据直接推荐补充剂量。

局限性

  • 荟萃分析仅能获取研究水平数据,而非个体水平数据。
  • 含4个SNP的遗传评分存在多效性证据,可能影响因果推断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Observational studies have reported that higher plasma 25-hydroxyvitamin D (25[OH]D) concentrations are associated with lower risks of diabetes, but it is unclear if these associations are causal. The aim of this study was to test the relevance of 25(OH)D for type 2 diabetes using genetically instrumented differences in plasma 25(OH)D concentrations. METHODS AND FINDINGS: Data were available on four 25(OH)D single nucleotide polymorphisms (SNPs; n = 82,464), plasma 25(OH)D concentrations (n = 13,565), and cases with diabetes (n = 5,565) in the China Kadoorie Biobank (CKB). The effects on risk of diabetes were assessed by a genetic score using two 25(OH)D synthesis SNPs (DHCR7-rs12785878 and CYP2R1-rs10741657), with and without the addition of SNPs affecting the transport (GC/DBP-rs2282679) and catabolism (CYP24A1-rs6013897) of 25(OH)D. The CKB results were combined in a meta-analysis of 10 studies for the 2 synthesis SNPs (n = 58,312 cases) and 7 studies for all 4 SNPs (n = 32,796 cases). Mean (SD) 25(OH)D concentration was 62 (20) nmol/l in CKB, and the per allele effects of genetic scores on 25(OH)D were 2.87 (SE 0.39) for the synthesis SNPs and 3.54 (SE 0.32) for all SNPs. A 25-nmol/l higher biochemically measured 25(OH)D was associated with a 9% (95% CI: 0%-18%) lower risk of diabetes in CKB. In a meta-analysis of all studies, a 25-nmol/l higher genetically instrumented 25(OH)D concentration was associated with a 14% (95% CI: 3%-23%) lower risk of diabetes (p = 0.01) using the 2 synthesis SNPs. An equivalent difference in 25(OH)D using a genetic score with 4 SNPs was not significantly associated with diabetes (odds ratio 8%, 95% CI: -1% to 16%, lower risk, p = 0.07), but had some evidence of pleiotropy. A limitation of the meta-analysis was the access only to study level rather than individual level data. CONCLUSIONS: The concordant risks of diabetes for biochemically measured and genetically instrumented differences in 25(OH)D using synthesis SNPs provide evidence for a causal effect of higher 25(OH)D for prevention of diabetes.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Lu L, Bennett DA, Millwood IY, et al. Association of vitamin D with risk of type 2 diabetes: A Mendelian randomisation study in European and Chinese adults. PLoS Med. 2018. PMID: 29718904. doi:10.1371/journal.pmed.1002566

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。